Journal article icon

Journal article

A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome.

Abstract:

BACKGROUND: Although few placebo-controlled neuroleptic discontinuation studies have been conducted in people with dementia, such studies are essential to inform key clinical decisions. METHOD: A 3-month, double-blind, placebo-controlled, neuroleptic discontinuation study (June 2000 to June 2002) was completed in 100 care-facility residents with probable or possible Alzheimer's disease (according to National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease ...

Expand abstract
Publication status:
Published

Actions


Authors


Ballard, CG More by this author
Expand authors...
Journal:
The Journal of clinical psychiatry
Volume:
65
Issue:
1
Pages:
114-119
Publication date:
2004-01-05
EISSN:
1555-2101
ISSN:
0160-6689
URN:
uuid:cbae1cf5-8c30-4abe-8ffd-0a8a0bcdcd56
Source identifiers:
111853
Local pid:
pubs:111853

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP